A recent study found that combination therapy against cancer are initially more expensive than a single agent therapies, while offering better outcomes for patients and are more profitable. Cancer Center Fox Chase Philadelphia simple treatments Teams explained that cancer could cost more in the long term due to expenditure on the treatment of complications of patients and cancer recurrence.
The findings were to be presented Tuesday at the annual meeting of the American Society for Therapeutic Radiology and Oncology in Philadelphia.
